“It takes a whole community to move new and impactful research like ours to clinics that eventually benefit patients,” says Dr He. “This can’t happen without the support of Canadian Cancer Society donors, as well as supporters of PCC and the Movember Foundation, all of whom made this research possible. “
“We identified thousands of a new type of RNA that have the potential to control tumour development and progression,” says Dr He. “The new molecules are extremely stable in blood, so they are very promising diagnostic markers and could also be used to predict metastasis.”
Dr He and his team also found that a subset of circular RNAs were important for tumour growth, making them potential targets for new RNA-based therapies.
The researchers are now testing whether circular RNAs in the blood can serve as markers to help diagnose prostate cancer earlier and less invasively and predict whether a cancer will come back or spread.
“Our study provided the first comprehensive, large-scale profile of circular RNAs in cancer. It opens up a whole new area of research in the cancer field,” says Dr He.
Do you want to help fund groundbreaking research so fewer men will be affected by cancer, as well as help reduce the burden of a diagnosis by providing support? Check out CCS Gifts, and purchase The Dad Project for someone you love.